|
...claims, which include claims that cover its lead anti-cancer compound, CTCE-9908, among others. CTCE-9908 designed to block CXCR4, a receptor found on the surface of cancer cells.
CTCE-9908 is part of a new generation of anti-cancer drug candidates that...
NOTE: All illustrations and photos
have been removed from this article.
More articles from BIOTECH Patent News
Human Genome Sciences obtains United States patent., September 01, 2005
Deltagen obtains United States patent., September 01, 2005
BioGenex obtains favorable patent ruling against Ventana., September 01, 2005
Sirna granted patent covering siRNAs targeting Huntington's Disease., September 01, 2005
Saliva Diagnostic receives favorable ruling in patent infringement lit..., September 01, 2005
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
